Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Accounts receivable, allowance for credit loss	$ (15,951)	$ (18,755)
Less unamortized deferred financing costs	$ 13,044	$ 11,050
Common shares, par value (in USD per share)	$ 0.01	$ 0.01
Common shares, shares authorized (in shares)	500,000,000
Common shares, shares issued (in shares)	269,814,956	268,282,592
Common shares, shares outstanding (in shares)	269,814,956	268,282,592